Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release May 23 2025

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · · 19 pages · English

Summary by 6ix AI

The report indicates a notable increase in revenue from the India and Europe segments, while the North America segment experienced a decline. Overall, the results reflect a resilient business performance and strategic focus on expanding its global footprint.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/press-release-may-23-2025-6

Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6

Glenmark Pharmaceuticals Limited on 6ix

In the deck

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases